Story thread · 3 reports / 3 sources

Adicet Bio reports lupus trial results, plans pivotal study

investing.com · 8h · first report

The coverage

  1. Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway

    endpts.com · 17m

  2. An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus

    biopharmadive.com · 3h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.